A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the ...

An organ transplant first, new details on ADA conference controversy, and more health news from Morning Rounds ...

After the failure of an experimental drug for Angelman syndrome, experts cautioned that there is still reason to think ...

A click, signature, or brief review should not magically transfer responsibility from an AI developer or platform to a physician,” a reader tells STAT.

In the months before killing her children, Lindsay Clancy repeatedly sought help for her deteriorating mental health.

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Theresa is the lead Morning Rounds writer, and her stories focus on gender-affirming care, reproductive health, and mental health. You can reach Theresa on Signal at theresagaff.97. From 2021 to 2023, ...

Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance ...

Today, a look at how some generative AI medical devices are getting on the market quickly. Plus: OpenEvidence’s new AI models ...

AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow ...